Analysis Tools|
Allele Symbol Allele Name Allele ID |
Gpr161tm1.2Smuk targeted mutation 1.2, Saikat Mukhopadhyay MGI:6357710 |
||||||||||||
| Summary |
2 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• all fetuses exhibit protrusive tectal defects (tectal hypertrophy) at E13.5-E17.5
|
|
• at E13.5
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• although fetuses survive to E18.5, no liveborn pups are recovered
|
|
• significant increase in nasal bone volume at E17.5
|
|
• hard palatal shelves are not fused along the midline
|
|
• mild cleft palate at E15.5 and E17.5
|
|
• underdeveloped nasal septum at E13.5 and E15.5
|
|
• ~98% of fetuses show anotia/microtia at E13.5- E18.5
|
|
• protrusive tectal defects are secondary to increased proliferation of midbrain neural progenitor cells
|
|
• at E13.5, cell proliferation is significantly increased in the ventricular zone of the midbrain, suggesting that protrusive tectal defects are secondary to increased proliferation of midbrain neural progenitor cells
• Gli1 expression is significantly increased in the dorsal midbrain at E13.5
• Shh signaling activity and upstream Wnt signaling activity are both increased in midbrain tissues at E13.5
|
|
• fourth ventricle is enlarged at E13.5
|
|
• midbrain protrusion is initially observed at E13.5 and at E15.5
|
|
• dorsal midbrain is enlarged by E15.5
• overall midbrain tissues are expanded
|
|
• mesencephalic vesicle is enlarged at E13.5
|
|
• tectum is extended at E13.5
• ~98% of fetuses exhibit protrusive tectal defects (tectal hypertrophy) at E13.5-E18.5
• protrusive tectal defects are partly due to increased midbrain neural progenitor cell proliferation
|
|
• spinal edema at E15.5
|
|
• brain herniation along with protruded meninges is detected in the mesencephalic ventricles at E17.5
• ~69% of fetuses exhibit encephalocele at E17.5-E18.5
|
|
• severe orofacial defects at E13.5
|
|
• cranial neural crest cell (CNCC)-derived craniofacial bone formation is impaired
• significant loss of mineralized skull and facial bones at E17.5
• however, overall head size and formation of palatine, interparietal and occipital bones are unaffected
|
|
• frontal bones even fail to form
|
|
• significant reduction in frontal bone volume at E17.5
|
|
• significant reduction in parietal bone segments and volume at E17.5
|
|
• widened mandible at E17.5
|
|
• significant reduction in mandibular bone volume at E17.5
|
|
• underdeveloped mandible at E13.5 and E15.5
|
|
• irregular shapes of maxillary bone at E13.5 and E15.5, with widened maxilla at E17.5
|
|
• significant reduction in premaxilla volume at E17.5
|
|
• significant reduction in maxillary bone volume at E17.5
|
|
• shortened maxillary bone at E13.5 and E15.5
|
|
• significant increase in nasal bone volume at E17.5
|
|
• hard palatal shelves are not fused along the midline
|
|
• mild cleft palate at E15.5 and E17.5
|
|
• underdeveloped nasal septum at E13.5 and E15.5
|
|
• ~98% of fetuses show anotia/microtia at E13.5- E18.5
|
|
• cranial neural crest cell (CNCC)-derived craniofacial bone formation is impaired
• significant loss of mineralized skull and facial bones at E17.5
• however, overall head size and formation of palatine, interparietal and occipital bones are unaffected
|
|
• frontal bones even fail to form
|
|
• significant reduction in frontal bone volume at E17.5
|
|
• significant reduction in parietal bone segments and volume at E17.5
|
|
• widened mandible at E17.5
|
|
• significant reduction in mandibular bone volume at E17.5
|
|
• underdeveloped mandible at E13.5 and E15.5
|
|
• irregular shapes of maxillary bone at E13.5 and E15.5, with widened maxilla at E17.5
|
|
• significant reduction in premaxilla volume at E17.5
|
|
• significant reduction in maxillary bone volume at E17.5
|
|
• shortened maxillary bone at E13.5 and E15.5
|
|
• significant increase in nasal bone volume at E17.5
|
|
• severe defects in intramembranous bone formation, involving cranial vault and facial bones
|
|
• ~98% of fetuses show anophthalmia/microphthalmia at E13.5- E18.5
|
|
• ~98% of fetuses show anophthalmia/microphthalmia at E13.5- E18.5
|
|
• ~98% of fetuses show anotia/microtia at E13.5- E18.5
|
|
• hard palatal shelves are not fused along the midline
|
|
• mild cleft palate at E15.5 and E17.5
|
|
• protrusive tectal defects are secondary to increased proliferation of midbrain neural progenitor cells
|
|
• significant increase in nasal bone volume at E17.5
|
|
• underdeveloped nasal septum at E13.5 and E15.5
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|
|
||
